-+ 0.00%
-+ 0.00%
-+ 0.00%
BioHarvest says Botanical Synthesis platform hits milestone in Tate & Lyle sweetener R&D program
Share
Listen to the news
BioHarvest says Botanical Synthesis platform hits milestone in Tate & Lyle sweetener R&D program
  • BioHarvest Sciences reached a key R&D milestone with Tate & Lyle in a next-generation sweetener development program.
  • Work showed BioHarvest’s Botanical Synthesis platform can produce the targeted sweetening solution, supporting the project’s technical feasibility.
  • Development continues in line with expectations, strengthening the case for broader sweetener innovation using the platform.
  • The result supports a strategic push to expand sugar-reduction options with improved consistency, supply reliability, sustainability potential.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioharvest Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001723464-26-000058), on October 08, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending